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Abstract
Background: Trypanosoma cruzi, an intracellular protozoan parasite that infects humans and other mammalian hosts, is the
etiologic agent in Chagas disease. This parasite can invade a wide variety of mammalian cells. The mechanism(s) by which T.
cruzi invades its host cell is not completely understood. The activation of many signaling receptors during invasion has been
reported; however, the exact mechanism by which parasites cross the host cell membrane barrier and trigger fusion of the
parasitophorous vacuole with lysosomes is not understood.
Methodology/Principal Findings: In order to explore the role of the Low Density Lipoprotein receptor (LDLr) in T. cruzi
invasion, we evaluated LDLr parasite interactions using immunoblot and immunofluorescence (IFA) techniques. These
experiments demonstrated that T. cruzi infection increases LDLr levels in infected host cells, inhibition or disruption of LDLr
reduces parasite load in infected cells, T. cruzi directly binds recombinant LDLr, and LDLr-dependent T. cruzi invasion
requires PIP2/3. qPCR analysis demonstrated a massive increase in LDLr mRNA (8000 fold) in the heart of T. cruzi infected
mice, which is observed as early as 15 days after infection. IFA shows a co-localization of both LDL and LDLr with parasites in
infected heart.
Conclusions/Significance: These data highlight, for the first time, that LDLr is involved in host cell invasion by this parasite
and the subsequent fusion of the parasitophorous vacuole with the host cell lysosomal compartment. The model suggested
by this study unifies previous models of host cell invasion for this pathogenic protozoon. Overall, these data indicate that T.
cruzi targets LDLr and its family members during invasion. Binding to LDL likely facilitates parasite entry into host cells. The
observations in this report suggest that therapeutic strategies based on the interaction of T. cruzi and the LDLr pathway
should be pursued as possible targets to modify the pathogenesis of disease following infection.
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Introduction
The Low-Density Lipoprotein receptor (LDLr) (UniProtKB:
P01130) is a cell surface glycoprotein that plays a critical role in
cholesterol homeostasis [1]. LDLr is the patriarch of an entire class
of receptors called LDL receptor related proteins (LRPs) that
contain similar structural modules [2]. The mature LDLr is a
modular type I transmembrane protein of 839 amino acids and is
composed of a number of functionally distinct domains that can
function independently of each other [3,4]. The N-terminus of the
receptor contains three types of extracellular modules consisting of
cysteine-rich repeats, three epidermal growth factor precursor
(EGFP) regions, and O-linked oligosaccharides followed by a
membrane spanning domain. The C-terminus domain of the
receptor contains a signal sequence (NPXY) that is needed for
receptor binding to clathrin pits and internalization [5]. The most
important physiologic ligand for the receptor is Low Density
Lipoprotein (LDL). Members of the LDLr superfamily bind a
variety of ligands including lipoproteins, proteinases and
proteinase-inhibitor complexes, and transport them into endo-
somes in the cell [6]. The functional properties of LDLr family
members include clustering of receptors into clathrin-coated pits
mediated by adaptor proteins, a pH sensitive ligand uncoupling
mechanism, and recycling of the receptors back to the cell
surface after dissociation of ligands. The transcription of LDL
receptor is regulated by intracellular cholesterol and extracel-
lular stimuli such as TNFa,I L - 1 b,T G F - b and insulin [7–9].
The signaling pathways leading to activation of Protein Kinase
C (PKC), Protein Kinase A (PKA) and intracellular Ca
2+
mobilization are also involved in LDLr expression [10]. LDL-
containing immune complexes upregulate LDLr transcription.
Interestingly, Pseudomonas exotoxin A and a minor group of
rhinoviruses have been reported to utilize LDLr members to
enter into host cells [11].
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Trypanosoma cruzi, affects millions of people in Mexico, Central and
South America. During acute infection clinical progressions may
include myocarditis and/or meningoencephalitis, although most
patients are asymptomatic. Chronic manifestations include
irreversible cardiomyopathy and megasyndromes [12–14]. Cur-
rent antiparasitic treatments are not effective for chronic infection.
T. cruzi invades a wide variety of mammalian cells including
macrophages, smooth muscle cells, striated muscle cells, fibro-
blasts, cardiomyocytes, and adipocytes [15,16]. In its vertebrate
host this parasite is transmitted from cell to cell by non-replicating
motile trypomastigotes which are capable of invading host cells;
following invasion trypomastigotes transform into amastigotes
which replicate intracellularly. In contrast to many intracellular
pathogens that avoid contact with host cell lysosmes, T. cruzi
requires the low pH environment of lysosomes to initiate egress
from the parasitophorous vacuole and delivery to the host cell
cytoplasm where replication begins [17–19] after approximately
24 hours post-invasion.
The molecular mechanism(s) of invasion by this parasite and the
associated regulatory pathways have been the subject of intense
investigation for many years. Two models of invasion, a lysosomal
dependent, and a phosphotidylinositol phosphates (PIPs) pathway
have been suggested for T. cruzi invasion. The lysosomal
dependent pathway postulates that T. cruzi elicited signals evoke
the early recruitment of host cell lysosomes to the cytosolic face of
the plasma membrane at the parasite attachment site where the
localized fusion of lysosomes provide membrane for the nascent
parasitophorous vacuole [20]. The proposed lysosome indepen-
dent PIP dependent parasite entry pathway is based on host cell
PI3K signaling as a key regulator of T. cruzi invasion [20,21].
However, neither of these models explains the precise mecha-
nism(s) by which this parasite traverses the host cell permeability
barrier and interacts with the lysosomal compartment.
Recent studies have demonstrated that T. cruzi activates many
cell membrane receptors such as Toll-like receptors (TLRs), kinins
(B1/B2 sub types), receptor tyrosine kinases, TGF and EGF
receptors and that the activity of these receptors is required for
optimal parasite binding and/or invasion [22–25]. In addition,
invasion results in the activation of ERK/MAPK signaling
pathways. Taken together these studies reveal that T. cruzi
activates many signaling pathways involving diverse receptors on
the host cell surface in preparation for internalization.
Our study highlights, for the first time, that LDLr is involved in
the trafficking of lysosomes to the parasitophorous vacuole
containing trypomastigotes and that inhibition or disruption of
LDLr affects the intracellular parasite load. We also report that
LDLr expression is upregulated in infected mouse hearts and
LDL/LDLr is associated with the amastigotes (pseudocysts) in the
heart tissue of infected mice. The accumulation of LDL and LDLr
in the heart probably contributes to the pathogenesis of chagasic
heart disease. The LDL/LDLr pathway could represent a new
therapeutic target for modulating T. cruzi infection.
Materials and Methods
Parasitology and pathology
The Brazil strain of T. cruzi was maintained in C3H/He mice
(Jackson Laboratories, ME). Six to 8 week old male CD-1 mice
were obtained from Charles River Laboratories (Wilmington, MA)
and infected IP with 5610
4 trypomastigotes. The serum and heart
tissues were collected at 15, 20 and 30 days p.i. The mice were
anesthetized with isoflurane and about 75 ml of blood is collected
from the orbital venous sinus. The mice were then observed for
recovery from anesthesia and returned to their cages. The
parasitemia was determined using a Neubauer hemocytometer.
Hearts were fixed in 10% buffered formalin and paraffin sections
were stained with IFA. The animal experiments were approved by
the Institutional Animal Care and Use 200Committees (IACUC)
of Albert Einstein College of Medicine (No.20100204). Parasites
were also maintained in L6E9 myoblasts as previously described
[26].
Mammalian cell culture
Human Foreskin Fibroblast (HFF) (ATCC CRL 1475), rat
cardiomyocyte H9c2 and 3T3-L1 (ATCC CL 173) cell lines are
maintained in our laboratory using standard methods as previously
published [27,28].
Materials
All the cell culture reagents used in these experiments were
obtained from Cellgro (Mediatech Inc.), primary antibodies were
obtained from Abcam (MA) and secondary fluorescence antibodies
were obtained from Invitrogen (CA) unless other suppliers are
specifically mentioned in the text. For each experiment a
minimum of 4 mice were used per group and each experiment
has been repeated thrice.
Immunoblot analysis
Cell lysates were prepared as previously described [29]. An
aliquot of each sample (40 mg protein) was subjected to 7.5% SDS-
PAGE and the proteins were transferred to nitrocellulose filters for
immunoblot analysis. LDLr specific rabbit monoclonal antibodies
(1:2000 dilution, ab52818 Abcam, MA) and horseradish peroxi-
dase- conjugated goat anti-rabbit immunoglobulin (1:5000 dilu-
tion, Amersham Biosciences) were used to detect specific protein
bands (explained in Figure Legends) using a chemilumines-
cence system [29]. GAPDH (1:5000 dilution, mouse monoclonal
Ab8245, MA and secondary antibody horseradish peroxidase
conjugated goat anti-rabbit 1:2000 dilution, Amersham Biosci-
ences) was used to normalize protein loading.
Author Summary
Trypanosoma cruzi, an intracellular protozoan parasite that
causes Chagas disease in humans and results in the
development of cardiomyopathy, is a major health
problem in endemic areas. This parasite can invade a
wide variety of mammalian cells. The mechanisms by
which these parasites invade their host cells are not
completely understood. Our study highlights, for the first
time, that the Low Density Lipoprotein receptor (LDLr) is
important in the invasion and the subsequent fusion of the
parasitophorous vacuole with host lysosomes. We dem-
onstrate that T. cruzi directly binds to LDLr, and inhibition
or disruption of LDLr significantly decreases parasite entry.
Additionally, we have determined that this cross-linking
triggers the accumulation of LDLr and phosphotidylinosi-
tol phosphates in coated pits, which initiates a signaling
cascade that results in the recruitment of lysosomes,
possibly via the sorting motif in the cytoplasmic tail of
LDLr, to the site of adhesion/invasion. Studies of infected
CD1 mice demonstrate that LDLs accumulate in infected
heart and that LDLr co-localize with internalized parasites.
Overall, this study demonstrates that LDLr and its family
members, engaged mainly in lipoprotein transportation,
are also involved in T. cruzi entry into host cells and this
interaction likely contributes to the progression of chronic
cardiomyopathy.
LDLr and T. cruzi Invasion
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Fibroblasts were cultured on cover slips to 80% confluence and
then infected with trypomastigotes (3.1610
6/cm
2 surface area of
culture plates) for 10, 20 and 30 minutes. The fibroblast cultures
were fixed with 4% paraformaldehyde, permeabilized with 0.1%
Triton 6100 (30min) and stained for LDLr/clathrin/PIP/
LAMP2/LDL using specific primary antibodies rabbit monoclonal
to LDLr (Ab52818), mouse monoclonal to Clathrin (1:200,
Ab2731), mouse monoclonal to PIP2 (1:300, Ab11039), rat
monoclonal LAMP1 (1:150, Hybridoma bank, 1D4B), rat
monoclonal to LAMP2 (1:150, Hybridoma bank, ABL93) and
goat anti human LDL (1:10, Sigma L 8016) respectively used with
the concentrations as recommended by the manufacturers and
Alexa fluor 594 (goat anti rabbit or anti mouse IgG 1:500 dilution;
Invitrogen, CA), or Alexa 488 (goat anti rabbit or anti mouse or
anti rat IgG 1:500 dilution; Invitrogen CA). The cells were stained
with DAPI (blue) to detect nuclei following manufacturer’s
protocols (www.abcam.com/ technical). Images were obtained
and analyzed by fluorescence microscopy using an inverted
Olympus IX71 with a HQ2 CCD camera and a Nikon
Microphot-FXA with Spot camera software. IFA of paraffin
embedded tissues were performed as previously published [30].
Inhibition of T. cruzi invasion by PCSK9
HFF cells were pretreated with recombinant proprotein
convertase subtilisin/kexin type 9 (0.5ug of PCSK9/cm
2 surface
area) for 1h at 37uC. PCSK9 treated and untreated cells were
incubated with trypomastigotes (3.1610
6/cm
2 surface area) for 1h
at 37uC. The cells were washed (5 times in phosphate buffered
saline (PBS, 7.2), fixed with 4% paraformaldehyde, permeabilized
with 0.1% Triton X-100 (30 min incubation) and stained with
DAPI. The number of parasites/2000 host cells was counted
under the microscope (406). The total number of parasites
counted in PCSK9 untreated cells was considered as 100%.
Double staining IFA of infected cells to differentiate
bound and invaded parasites
Fibroblast cells were incubated with parasites (MOI 5:1) for 1h,
washed to remove unbound parasites, fed with fresh medium and
incubated at 37uC. At 4, 15 and 24h post infection, the cells were
fixed with 4% paraformaldehye, blocked in 3%BSA, incubated
with anti-parasite mouse serum (serum of infected CD1 mice 1:20
dilution) and secondary antibody fluorescent Alexa 480 (green) to
stain parasites bound to the cell surface. Then the cells were
permeabilized with 0.2% Triton X-100, blocked in 3%BSA,
incubated with anti- parasite mouse serum and secondary
antibody fluorescence Alexa 594 (red) to stain intracellular
parasites.
Binding of parasite with recombinant human LDLr
Trypomastigotes (1.8610
6) were washed twice in PBS and
incubated with 5 mg of recombinant hu-LDLr (2148-LD/CF,
R&D Systems, Inc.) for 1h at room temperature (final concentra-
tion 10ng/ul). The incubation mixture was centrifuged at
5000 rpm for 5min, washed twice in DMEM (Dulbecco’s
Modified Eagle Medium) and surfaced on lysine treated cover
slips for 20 min before fixing with 4% paraformaldehyde (30min).
IFA was performed for bound parasites using LDLr specific
monoclonal antibody (1:100 dilution, for 1h at 37uC) and IgG goat
Alexa fluor 594 (1:500 dilution for 1h at 37uC).
As an alternative method we used recombinant hu-LDLr dye
conjugate (Alexa fluor 488, prepared as per Invitrogen protocol) to
incubate with trypomastigotes for 1hr at room temperature. The
parasites were then centrifuged at 5000 rpm for 5 min, washed
with DMEM (2 times) and surfaced on lysine treated cover slips for
20 min before fixing with 4% paraformaldehyde. GAPDH dye
conjugate was prepared as above and used as control.
RNA extraction and qPCR analysis
Total RNA was extracted from the heart tissue of CD1 infected
mice using Trizol reagent (Invitrogen). Further cleaning up of
RNA was performed using RNeasy minikit (QIAGEN Sciences,
Maryland) according to the manufacturer’s instructions. Reverse
transcription of total RNA and the quantitative PCR was carried
out as described earlier using iQ5 BioRad system [16]. The LDLr
mRNA levels were detected using PCR arrays designed by
SABiosciences (PAMM-030) following manufacturer’s instruc-
tions.
DNA extraction and qPCR analysis of parasite load
Wild type and LDLr KO cells (mouse embryonic fibroblast)
[31] were incubated with trypomastigotes (3.1610
6/cm
2 surface
area) for 1h at 37uC. The cells were washed four times in PBS to
remove unbound parasites and incubated in DMEM containing
10% FBS for 68 hrs at 37C. Parasite load in these cells was
quantitated by real-time PCR as previously described [29].
Quantification of serum LDL, HDL and triglycerides in
CD1 mice
Serum collected at day 15, 20 and 30 p.i. from CD1 infected
and uninfected mice were used to quantitate serum LDL, HDL
and triglyceride levels using E2HL-100 (EnzyChrom AF HDL and
LDL/VLDL Assay Kit) following manufacturer’s protocol.
Results
T. cruzi infection increases LDLr levels in infected host cells
Endocytosis of LDL receptor (LDLr) in association with calcium
mobilization, its subsequent trafficking to lysosomes, and the
release of ligands at low pH are processes reminiscent of those
involved in T. cruzi invasion. Interestingly, some rhinoviruses use
LDLr members to enter into host cells [11]. We hypothesized that
T. cruzi may utilize host LDLr to enter the host cells. The
association of LDLr with T. cruzi invasion and infection was
therefore investigated using in vitro infection of human fibroblast
cells (HFF) and murine cardiomyocytes (H9c2). Immunoblot
analysis of LDLr protein levels in cell lysates from infected HFF
and H9c2 cells using LDLr specific monoclonal antibodies
demonstrated that HFF and H9c2 cells incubated with T. cruzi
had a two-fold increase in LDLr protein levels within 1h post-
infection (p.i.) (Figure 1A and B). The monoclonal LDLr
antibodies used in these studies were raised against the synthetic
peptide corresponding to residues from the C-terminus of the
human LDLr. To determine the distribution of LDLr proteins in
uninfected and infected cells immunofluorescence analysis (IFA)
was performed using LDLr specific monoclonal antibodies
(Figure 1C). IFA of uninfected fibroblasts demonstrated an even
distribution of LDLr around the cell membrane. In contrast, there
was a clustering of LDLr in infected cells (10 min p.i.) at the cell
membrane suggesting a role for LDLr in infection. These
antibodies did not cross react with T. cruzi alone (Figure S1).
Inhibition or disruption of LDLr reduces parasite load in
infected cells
To investigate the role of LDLr in parasite trafficking, we pre-
incubated HFF cells with exogenous recombinant proprotein
LDLr and T. cruzi Invasion
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binds to the extracellular domain of LDLr and induces LDLr
degradation [32]. The PCSK9 pretreated cells demonstrated a
42% reduction in T. cruzi invasion compared to untreated cells
(Figure 2A). Immunoblot analysis of PCSK9 pretreated cells
demonstrated no significant difference in LDLr levels between
uninfected and infected HFF cells (Figure S2).
To determine whether parasites can invade the cells in the
absence of LDLr, we infected embryonic fibroblast cells derived
from LDLr KO mice [31]. Immunoblot analysis confirmed the
absence of full length LDLr (120 kDa) protein in KO cells
compared to wild type cells (Figure 2B). It should be noted,
however, that these LDLr-KO cells express a truncated LDLr as
previously demonstrated by Ishibashi [31]. This truncated version
(based on the original gene KO) lacks the domains for binding
LDL and for internalization. When cells were incubated with T.
cruzi for 1h and assayed at 68 hrs there was a 62% reduction in
total parasite load in LDLr-KO cells compared to wild type using
a qPCR method (Figure 2C). Parasites bound strongly to the cell
surface in these LDLr KO cells and could not be dislodged even
with extensive washings with PBS. A kinetic study of parasite
invasion using a double staining IFA method demonstrated that
parasites rapidly invaded wild type cells, but were retarded (70%)
from invading the LDLr-KO cells (Figure 2D). Binding versus
internalization assays performed after 15 hrs of incubation with
parasites using double staining IFA showed significantly less
internalized parasites in KO cells compared to wild type (Figure
S3). We observed a reduced LDLr protein (truncated) expression
in KO cells compared to wild type full length LDLr (data not
shown). IFA demonstrated that clustering of the disrupted LDLr
still occurred at the cell membrane and that the disrupted LDLr
remained associated with internalized parasites in infected KO
cells similar to that of wild type (Figure 2E). Parasite binding was
noted to occur in the vicinity of this truncated LDLr in these KO
cells (Figure 2F). We do not know whether this association of
truncated protein with the parasite is involved in parasite
internalization (30% compared to wild type) or if other members
of LDLr family are involved in the absence of full length LDLr.
Overall, these results supported the hypothesis that LDLr plays an
important role in mediating T. cruzi invasion.
T. cruzi exploits LDLr to invade mammalian cell
The activation of various cell surface receptors and signaling
pathwaysby T. cruzi has been reported by otherinvestigators[22–25].
To examine if trypomastigotes utilize LDLr to activate certain
signalingpathwaystoenterthehostcellsorifLDLr-assistedpathways
are involved in internalization, we performed IFA to observe the
localization of LDLr in infected cells. IFA of HFF cellsincubated with
trypomastigotes demonstrated an association of LDLr with internal-
ized parasites within 10 min of incubation (Figure 3A).
It was previously reported that T. cruzi has an affinity for
binding to LDL [33]. We performed IFA of thoroughly washed
parasites using LDL specific antibodies and observed no signals for
the presence of LDL (data not shown). To ascertain whether
trypomastigotes can directly bind to LDLr or use LDL as a bridge
to bind to LDLr, we performed binding studies using recombinant
human LDLr (huLDLR Ala22-Arg788). We incubated washed
parasites with recombinant LDLr and carried out IFA as described
in experimental procedures. IFA using monoclonal LDLr
antibodies demonstrated the association of recombinant LDLr
with the parasites (Figure 3B). An alternative experiment with
fluorescent labeled LDLr also confirmed direct binding between
parasites and the LDLr (Figure 3C). Fluorescent labeled GAPDH
(control protein) did not bind to parasites and the monoclonal
LDLr antibody did not bind to the parasite in the absence of
preincubation of parasites with LDLr.
LDLr- Dependent T. cruzi invasion requires PIP2/3
The endocytosis of LDLr and its associated adaptor proteins,
including clathrin and PIPs, has been extensively studied.
Accumulation of PIP2 and PIP3 at the penetration site of
trypomastigotes has been reported [34]. To further confirm the
association of PIPs to LDLr during parasite invasion we performed
double staining IFA with antibodies specific for LDLr and PIP2/3.
IFA demonstrated the co-localization of LDLr and PIPs with
invaded parasites in infected HFF cells (Figure 4A).
It had been previously reported that inhibition of dynamin (a
protein involved in clathrin-mediated endocytosis), drastically
diminished T. cruzi entry in both phagocytic and non-phagocytic
cells [35]. To investigate the involvement of clathrin in T. cruzi
invasion, we performed IFA of 30 min infected HFF cells using
clathrin specific monoclonal antibodies. The results as demon-
strated in Figure 4B corroborate the involvement of clathrin in the
invasion of extracellular parasites into host cells. These antibodies
did not cross react with T. cruzi alone (Figure S1).
T. cruzi targets LDLr in trafficking to host cell lysosomes
The functional properties of LDLr family members include
clustering of receptors into clathrin-coated pits mediated by
adaptor proteins, a pH sensitive ligand uncoupling mechanism,
and recycling of the receptors back to the cell surface after
dissociation of ligand in endosomes [1]. We wanted to ascertain
Figure 1. LDLr expression in T. cruzi infected host cells. A.
Immunoblot analysis of LDLr in infected cells. Increased LDLr levels
were observed in both infected HFF cells (upper panel) and H9c2 cell
lines (lower panel) after 1h incubation with parasites. B. Quantitative
analysis of immunoblots. Arbitrary units of the expressed LDLr proteins
normalized to respective GAPDH levels represented in the bar
histogram as quantitated using Alpha Ease FC software. C- control, I-
infected, C(HFF)- control HFF cells, I(HFF)- infected HFF cells, C(H9c2)-
control H9c2 cells and I(H9c2)- infected H9c2 cells (n=4 and p,0.05
represented as star). C. Distribution of LDLr in uninfected and infected
fibroblast cells. IFA demonstrated an even distribution of LDLr at cell
membrane in uninfected cells, but clustering of LDLr in infected cells
after 15 minutes of incubation with parasites (arrows). (Host nu-
cleus<HN, bar represents 50mm).
doi:10.1371/journal.pntd.0000953.g001
LDLr and T. cruzi Invasion
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cells or co-exist while fused with endosomes/lysosomes in order to
gain entrance to the acidic environment important for transfor-
mation from trypomastigotes to amastigotes. Therefore, we
employed double staining IFA using lysosome associated mem-
brane proteins (LAMP-1 and 2) specific antibodies (Figure 4C and
4D). Fibroblast cells infected with trypomastigotes for 30 min
showed the presence of lysosomes surrounding the invaded
parasites in association with LDLr. These antibodies did not cross
react with T. cruzi alone (Figure S1).
Role of LDLr in in vivo T. cruzi infection
T oi n v e s t i g a t et h er o l eo fL D L ri naT. cruzi infected mouse model,
we infected CD1 mice with trypomastigotes and analyzed for LDLr
mRNA levels in heart tissue 15 day p.i. qPCR demonstrated a
significant increase in the mRNA levels of LDLr up to 8000 fold in
infected heart tissue compared to control mice (Figure 5A). A serum
lipid analysis was performed to examine any changes in LDL, HDL
a n dt r i g l y c e r i d el e v e l si ni n f e c t e dm i c ec o m p a r e dt ou n i n f e c t e dm i c e
(Figure 5B). LDL levels in infected mice significantly decreased with
time (22% by 15 day p.i. and 50.5% by 30 day p.i.) compared to
Figure 2. Inhibition/disruption of LDLr reduces parasite load in infected cells. A. PCSK9 pretreatment reduced parasite invasion. Incubation
of parasites with PCSK9 pretreated HFF cells reduced parasite load by degrading LDLr. The bar histogram demonstrates the parasite load in PCSK9
pretreated and untreated HFF cells (n=4 and p,0.05 represented as an ‘‘*’’). B. Immunoblot analysis of LDLr in wild type and LDLr KO cells.
Immunoblot analysis using monoclonal LDLr antibodies confirmed the lack of full length LDLr at 120 KD (represented by arrow) in KO cells. However,
LDLr KO cells express a truncated LDLr which lacks the LDL binding domain (27). C. Quantitative analysis of parasite load in infected wild type and
LDLr KO cells. Reduced parasite load in LDLr KO cells after 68h of infection compared to infected wild type cells demonstrated by real time PCR
analysis. Bar histogram represents the parasite load (%) in infected cells. D. Kinetic studies of parasite binding and invasion in LDLr KO cells. Lack of
full length LDLr protein in LDLr KO cells reduced the number of parasites attached to cell membrane (Upper line) and also retarded the parasite
invasion (lower line), demonstrated by IFA as described under experimental procedures. E. IFA of LDLr in infected LDLr KO cells. IFA using monoclonal
LDLr antibodies (red) demonstrated the clustering of disrupted LDLr around the structures similar to parasites (arrow) in KO cells (bar represents
50mm). F. Co-localization of parasites with disrupted LDLr in infected KO and wild type cells. Double staining IFA using infected mouse serum (green)
and monoclonal LDLr antibodies (red) demonstrated the co-localization of parasites with disrupted LDLr (top panel) and full length LDLr (lower
panel). (bar represents 50mm).
doi:10.1371/journal.pntd.0000953.g002
LDLr and T. cruzi Invasion
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(15 day p.i.) using LDLr specific monoclonal antibodies (Figure 5C)
demonstrated the co-localization of LDLr to the specific area
surrounding invaded parasites in hearttissue. We also performed IFA
of LDL using LDL specific polyclonal antibodies in these tissues and
the results confirmed an accumulation of LDL along with LDLr
around intracellular parasites in the hearts of infected mice
(Figure 5D). These results demonstrate that in addition to the
increase in LDLr mRNA levels in inf e c t e dt i s s u e st h e r ew a sa l s oa
localization of LDLr as well as LDL to areas of pseudocysts
containing thousands of parasites.
Discussion
LDLr family members share similar structural homology and
are involved in lipoprotein and other ligand endocytosis events.
Internalization of ligands by LDLr is a complex process which
requires a vast assembly of structural coat components and a host
of accessory proteins to drive the endocytic machinery. Many
signaling pathways and secondary messengers are involved in this
process. The mechanisms involved in LDLr endocytosis are
similar to that of T. cruzi internalization such as, calcium
mobilization, fusion with endosomes/lysosomes, and the require-
ment of an acidic pH environment. We therefore explored the
possible involvement of LDLr in T. cruzi invasion.
The in vitro and in vivo observations in the current manuscript
confirm that T. cruzi utilizes the LDLr in their host cell invasion
process. The interaction between T. cruzi and host cells has been
extensively reviewed [36–38]. Earlier reports demonstrate that a
variety of host receptors become activated during T. cruzi binding
and invasion. For example, activation of TLR2 mediated Rab-5 in
T. cruzi invasion has been explored. TNF-a, interleukins and
cytokines are regulated by TLR-2 activation. Two other receptors
namely, ‘‘transforming growth factor b receptor and bradykinin
receptor’’ have also been reported to be involved in T. cruzi
infection [23,25]. Melo-jorge and Pereira Perrin demonstrated the
involvement of receptor tyrosine kinases during T. cruzi invasion
[24]. Based on these reports, we propose that T. cruzi binds to host
cell membrane receptors and activates many signaling pathways
mainly involved in cell proliferation, PI3kinase activation, MAPK
signaling and transcription factors, since all these components are
known to positively regulate LDLr transcription [7–10].
Our results demonstrate that the parasites directly bind to LDLr
and inhibition or disruption of LDLr resulted in a reduced rate of
invasion. This mechanism of invasion is associated with PIPs and
clathrin. It had been previously reported that inhibition of
dynamin (a protein associated in clathrin-mediated endocytosis),
drastically diminished T. cruzi entry in both phagocytic and non-
phagocytic cells [35]. Earlier reports have demonstrated the
accumulation of PIP2/3 around the parasite penetration site and
Figure 3. T. cruzi targets LDLr during invasion as demonstrated by IFA. A. Association of LDLr with T. cruzi during invasion. IFA of LDLr in
Infected HFF cells showed the co-localization of LDLr (red) with parasite. The cells were stained with DAPI (blue) to detect nucleus (bar represents
50mm). B. Binding of parasite to recombinant human LDLr. IFA demonstrated the direct binding of parasite with exogenously added recombinant
huLDLr using monoclonal antibodies specific for LDLr (bar represents 50mm). C. Direct binding of parasite to Fluorescence labeled recombinant
huLDLr. Fluorescent labeled huLDLr bound to the parasites on their cell surface demonstrated by fluorescent microscopy (left) and stained with DAPI
(center). Alexa fluor 488 labeled GAPDH dye conjugate is used as a control (right). (bar represents 10mm).
doi:10.1371/journal.pntd.0000953.g003
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in decreased parasite entry [21,34,39]. Here, we report that
phosphotidylinositol bis phosphate (PIP2) co-localized to the
LDLr/parasite complex (Figure 4A). These data are consistent
with the earlier observation of a lysosome independent pathway
for parasite invasion [17–20]. It is probable that T. cruzi uses the
sorting motif in the cytoplasmic tail of LDLr to recruit the host
lysosomes to the site of invasion, which provides the acidic
environment to the parasite for its transformation to amastigotes.
IFA demonstrated the co-localization of lysosomes around the
parasite associated LDLr complex (Figure 4C). While these results
are consistent with a role for LDLr in T. cruzi internalization and
trafficking to host lysosomes, the exact mechanism through which
LDLr recruits the lysosomes to the site of invasion will require
further studies. Overall, these observations indicate that both of
the current models that exist for T. cruzi invasion (i.e lysosome-
dependent and PIPs dependent) are part of the same model in
which the LDLr complex machinery connects and completes the
process of invasion by this pathogenic microbe.
Our studies employing wild type and LDLr KO cells suggest
that the presence of full-length LDLr facilitates the binding and
internalization of parasites. Disruption of LDL binding domains
retarded both parasite binding and invasion. IFA revealed that
parasites could still associate with the truncated LDLr expressed in
LDLr-KO cells. The KO lacks the LDL binding domain but
contains other functional regions of the LDLr including the C
terminus. The monoclonal LDLr antibodies employed were raised
against the synthetic peptide corresponding to residues from the
C-terminus of the human LDLr. The NPXY motif at the C-
terminal sequence of LDLr is involved in the internalization
signaling [5] and persists in the KO construct. Further
investigations will be necessary to determine if other members of
the LDLr family are also involved in parasite invasion in the
absence of full length LDLr or if the truncated LDLr itself was
involved in the reduced rate (30% of wild type) of parasite
internalization seen in the LDLr KO cells.
Acutely infected mice displayed a significant decrease in plasma
LDL levels. In addition, LDL was increased at areas where
parasites were present in the heart. The infection-associated
increase in phospholipids, triglycerides, and fatty acids could
contribute to the pathogenesis of chagasic heart disease [40]. Our
data strongly suggest that LDLr and its family members play an
important role in T. cruzi invasion and the subsequent lysosomal
recruitment that facilitates transformation of trypomastigotes into
amastigotes. LDL may facilitate parasite entry and also contribute
to LDL-parasite immune complexes regulating LDLr levels [41].
Further research on the mechanism by which this parasite
interacts with the host LDLr/clathrin complex is justified. In
addition, the observations in this report suggest that therapeutic
strategies based on the interaction of T. cruzi and the LDLr
pathway should be pursued as possible targets to modulate the
consequences of infection.
Figure 4. Role of LDLr and its associates in trafficking T. cruzi into host lysosomes. A. PIP2/3 is associated with LDLr during invasion. Co-
localization of PIP2/PIP3 (green) and LDLr (red) with parasite (DAPI) is demonstrated by triple staining IFA. B. Parasite utilizes LDLr/clathrin complex to
enter host cells. Triple staining IFA of infected 3T3-L1 cells demonstrated the co-localization of clathrin (green) with LDLr (red) and parasites (DAPI). C.
Presence of LDLr during lysosomal fusion with parasites during infection. Parasite trafficking to lysosomes (LAMP1- green) by LDLr (red) is
demonstrated by the co-localization lysosome, LDLr and parasite as shown by IFA. (green arrow represents the presence of LAMP1 around
parasitophorous vacuoles. D. Co-localization of total LAMP-2 with parasites during infection. Triple staining IFA demonstrated the co-localization of
LAMP-2 (green) with LDLr (red) and parasites (DAPI) (bar represents 50mm).
doi:10.1371/journal.pntd.0000953.g004
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Figure S1 LDLr, Clathrin, LAMP antibodies do not cross react
with parasite alone. Double staining IFA demonstrated no cross
reactivity with parasites alone. Equivalent amounts of LAMP-1
and LAMP-2 antibodies were used and demonstrate that none
of these antibodies cross reacts with T. cruzi (bar represents
50 mm).
Found at: doi:10.1371/journal.pntd.0000953.s001 (1.03 MB
TIF)
Figure S2 Immunoblot analysis of LDLr in PCSK 9 treated
cells. Cell lysates from T. cruzi infected (1h p.i.) PCSK9 treated
cells were analyzed for LDLr expression by immunoblot. No
change in LDLr level was observed between uninfected and
infected cells in contrast to PCSK9 untreated cells (Figure 1A).
Found at: doi:10.1371/journal.pntd.0000953.s002 (0.08 MB
TIF)
Figure S3 Binding versus internalization in LDLr KO cells.
Double staining IFA of wild type (A) and LDLr KO (B) cells
demonstrated the reduced number of internalized parasites (bright
red) in KO cells compared to wild type and the presence of bound
parasites in both wild type and KO cells (yellow) (bar represents
50 mm).
Found at: doi:10.1371/journal.pntd.0000953.s003 (0.83 MB
TIF)
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